CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980376008
- Phone
- 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-10-31 | Slager David Mark Director | Option exercise · Warrant (right to buy) | −16,892 | $1.18 | $20K | 0 |
| 2017-10-23 | Sank Leonard Director | Option exercise | +5,631 | $6.00 | $34K | 287,789 |
| 2017-10-23 | Sank Leonard Director | Option exercise | +6,373 | $6.00 | $38K | 294,162 |
| 2017-10-23 | Sank Leonard Director | Option exercise · Warrant (right to buy) | −5,631 | $1.18 | $7K | 0 |
| 2017-10-23 | Sank Leonard Director | Option exercise · Warrant (right to buy) | −6,373 | 0 | ||
| 2017-08-17 | Slager David Mark Director | Option exercise | +112,613 | $3.77 | $424K | 1,299,436 |
| 2017-08-17 | Slager David Mark Director | Option exercise · Warrant (right to buy) | −112,613 | $1.18 | $133K | 0 |
| 2017-08-15 | Sank Leonard Director | Option exercise | +11,262 | $6.00 | $68K | 282,158 |
| 2017-08-15 | Sank Leonard Director | Option exercise · Warrant (right to buy) | −11,262 | $1.18 | $13K | 0 |
| 2017-08-02 | Li Xiaopeng Director | Purchase | +89,636 | $8.50 | $762K | 206,350 |
| 2017-08-02 | Kidron Miriam Chief Scientific Officer | Sale | −89,636 | $8.50 | $762K | 75,000 |
| 2017-06-30 | Zommer Yifat Hen CFO, Treasurer and Secretary | Grant or award · Stock Option (right to buy) | +20,001 | 20,001 | ||
| 2017-06-30 | Slager David Mark Director | Grant or award · Stock Option (right to buy) | +16,773 | 16,773 | ||
| 2017-06-30 | Sank Leonard Director | Grant or award · Stock Option (right to buy) | +16,773 | 16,773 | ||
| 2017-06-30 | RAKIN KEVIN Director | Grant or award · Stock Option (right to buy) | +56,773 | 56,773 | ||
| 2017-06-30 | KIDRON NADAV President and CEO | Grant or award · Stock Option (right to buy) | +147,000 | 147,000 | ||
| 2017-06-30 | Kidron Miriam Chief Scientific Officer | Grant or award | +75,000 | 164,636 | ||
| 2017-06-30 | Kidron Miriam Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +69,999 | 69,999 | ||
| 2017-06-30 | Li Xiaopeng Director | Grant or award · Stock Option (right to buy) | +16,773 | 16,773 | ||
| 2017-06-30 | Friedman Aviad Director | Grant or award · Stock Option (right to buy) | +16,773 | 16,773 |
Page 15 of 18 · 349 trades